VAERS reports by lot

Sanofi Pasteur DTaP/Tdap lot U6922AA: VAERS reports

33 VAERS reports list lot U6922AA as a Sanofi Pasteur DTaP/Tdap vaccine, received between 2021-08-05 and 2023-07-24. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
33
Reports
3%
Marked serious
0
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction533%
General / Systemic (non-local)427%
Musculoskeletal320%
Neurological17%
Cardiac / Cardiovascular17%
Dermatological (non-injection-site)17%

Where reports came from

U.S. state of the reporter, where given (top 12).

Indiana3
Michigan3
Ohio3
New Jersey3
California2
South Carolina2
Washington2
Georgia2
Virginia2
Delaware1
North Carolina1
Connecticut1

Reports by month received

2021-081
2021-101
2022-021
2022-031
2022-061
2022-072
2022-081
2023-0110
2023-029
2023-033
2023-041
2023-072

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.